Navigation Links
Hill-Rom Reports Third Quarter Financial Results
Date:8/6/2009

ted to performance issues on a discontinued product. Our operating expenses, exclusive of Liko, actually declined by $18 million or 13.1 percent thanks to the previously announced structural changes we have made, continued stringent internal cost controls and foreign exchange movements."

Soderberg concluded, "While we cannot predict the timing of when hospitals and other providers around the world will return to more normalized capital acquisition behavior, we are using this recessionary period, and the mandate we undertook when we affected the spin some five quarters ago, to prepare the company for strong and profitable growth once demand for our products--key tools in delivering safer and more efficient healthcare--inevitably returns. Based on the strength of our earnings performance during the quarter, we are also increasing our earnings guidance for this fiscal year."

Other third quarter revenue highlights regarding Hill-Rom business segments include:

-- North America Acute Care. Hill-Rom North America Acute Care revenue declined $30.8 million, or 14.0 percent, to $189.1 million. Capital sales decreased 20.1 percent, or $31.8 million, consistent with the outlook we provided in January contemplating a 15-30 percent decline in our hospital capital sales. Rental revenue increased by $1.0 million, or 1.6 percent, driven by mid-single-digit growth of therapy rental products.

-- International and Surgical. Hill-Rom International and Surgical capital and rental revenue decreased $1.9 million, or 1.9 percent, to $95.7 million. On a constant currency basis revenue growth was 7.9 percent as sales from the Liko acquisition were partially offset by volume declines in select European and rest of world countries as a result of softening in capital spending. Capital sales were essentially flat while rental revenue declined by $1.6 million.

-- No
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
2. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
3. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
4. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
5. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
6. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
7. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
8. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
9. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
10. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
11. Hill-Rom to Present at the Citi Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., (Seattle, Washington) November 20, 2009Emergenc...ates assess an estimated 350,000 cardiac arrests e... sudden cardiac arrest survive. Better quality ca...ospital EMS providers may be associated with bette...sortium (ROC) is the largest clinical research net...
(Date:11/20/2009)... Consumers save up to one-third buying 90-day supp...lthDay News) -- Buying a three-month supply of pre...ying a one-month supply, according to a new study....ns filled for 395 drugs between 2000 and 2005, and...ly instead of a one-month supply saved an average ...
(Date:11/20/2009)..., Longtime OB/GYN warns a...sed by the U.S. Preventative Services Task Force. ...ome at the price of human lives. When is it wrong ...The new U.S. Preventative Services Task Force reco... Annals of Internal Medicine, has set off a firest...
(Date:11/20/2009)..., , MOUNTAIN VIEW, Calif., Nov. 20 /PRN...L ) a leading provider of system solutions to acut...ny will present at the 21st Annual Piper Jaffray ...l, New York, NY. ,, Omnicell Speakers: Rand...EO and Rob Seim, vice president & CFO ,, D...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 To...nnel retailer HSN announce the launch of a capsule... and HSN.com for the holiday season. This collect...ldren,s Research Hospital,s Thanks and Giving...rogram which encourages consumers to "give thanks ...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3
...s ,Bad Public Policy, WASHINGTON, Sept. 27 - A gr...estern Reserve University professors Max,Mehlman a...rdensome,prohibitively expensive and would come at... health courts would require,the creation of new a...
...al Development, Highlight, Professional Developme... CINCINNATI, Sept. 27 Kendle (Nasdaq: KNDL ), a...ganization, today,announced that Vice President, G...ch on Friday, Sept. 28 at 9 a.m. The,presentation,...
...Rodgers, and Weiner, ALEXANDRIA, Va., Sept. 27 T...A) today applauds the official launch,of the bipar...The,Coalition,s primary objective is to preserve p... reside in underserved,rural and urban communities...
...Flynn Pharma,Limited, a specialty pharmaceutical c...oprietary products in secondary healthcare and rel...usive marketing and,distribution rights to DepoDur...go: http://www.newscom.com/cgi-bin/prnh/20070618/...
...Nasdaq: PRGO ; TASE) announced today that it had ...or Guaifenesin Extended-Release Tablets, 600 mg, a...sin extended-release tablets, 600 mg), an expector...disers for the 12 months ended August 2007, as mea...
... Help Consumers Measure Their ...ay the creators of,the "Life ... supplemented" cam...lphaWells, Wells, WannabeWells or OhWells. With th...easure their,wellness regimen and determine where ...
Other Medicine News:Health News:New Report Says 'Health Courts' Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights 2Health News:Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007 2Health News:Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007 3Health News:Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007 4Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 2Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 3Health News:Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe 2Health News:Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe 3Health News:Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory 2Health News:Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory 3Health News:Are You An AlphaWell or An OhWell? 2
(Date:11/19/2009)... Part of International Internet Week of Action ,...swire/ -- The U.S. Food and Drug Administration to...al effort, called the International Internet Week ... involving medical products. ,, (Logo: http://..., During the effort, the FDA,s Office of Crimina...
(Date:11/19/2009)...WPORT NEWS, Va., Nov. 19 Breast-Sp...I/MBI) has been recognized and endorsed by two hig...reast cancer: The Society of Breast Imaging (SBI) ...es published articles supporting the further appli... the early detection of breast cancer. ,, "Thes...
(Date:11/19/2009)..., Part of International Internet Week of Action ...wswire/ --The U.S. Food and Drug Administration to...al effort, called the International Internet Week ... involving medical products. ,, (Logo: http:/...,, During the effort, the FDA,s Office of Crimi...
Breaking Medicine Technology:UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3FDA Issues 22 Warning Letters to Web Site Operators 2Scientists ID First Human With Gorilla Strain of HIV 53433 1Scientists ID First Human With Gorilla Strain of HIV 53433 2Rock Climbing Injury Rate Soaring 53430 1Rock Climbing Injury Rate Soaring 53430 2Laurence I Barsh DMD Founder of Snoring Isn 26apos 3Bt Sexy to speak at Somnomed 26apos 3Bs First Annual Symposium 53426 1Laurence I Barsh DMD Founder of Snoring Isn 26apos 3Bt Sexy to speak at Somnomed 26apos 3Bs First Annual Symposium 53426 2
...creditation , , PALM BAY, Fla., April 17 To addr...ficials at the Florida Division of Midwest Researc...stablished a Clinical Molecular Diagnostics Labora...erational. , , MRI, headquartered in Kansas City,...cientific research organizations conducting contra...
...e for Treatment of Allergy , , SAN DIEGO , April...tical company focused on the development of novel ...ment of cancer, respiratory and inflammatory disea... I clinical trial of VTX-1463, a selective intrana...nitis. The objectives of this trial will be to ass...
Other Medicine Technology:Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory 2Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory 3VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
awarix Enterprise Visibility Solutions for Healthcare
Radianse Indoor Positioning Patient Location
VACUETTE Paediatric Multi-Sample Needle
BD Vacutainer Passive Shielding Blood Collection Needle
Medicine Products: